Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mavrogeni, S.
Right arrow Articles by Cokkinos, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mavrogeni, S.
Right arrow Articles by Cokkinos, D. V.
(Chest. 2005;127:143-148.)
© 2005 American College of Chest Physicians

Cardiac and Sternocleidomastoid Muscle Involvement in Duchenne Muscular Dystrophy*

An MRI Study

Sophie Mavrogeni, MD; George E. Tzelepis, MD, FCCP; George Athanasopoulos, MD; Themistoklis Maounis, MD; Marouso Douskou, MD; Antigoni Papavasiliou, MD and Dennis V. Cokkinos, MD

* From the Onassis Cardiac Surgery Center (Drs. Mavrogeni, Athanasopoulos, Maounis, and Cokkinos), University of Athens Medical School (Dr. Tzelepis), Athens, Greece; and Bioiatriki MRI Unit (Dr. Douskou), Athens, Greece; and the Pentelis Children’s Hospital (Dr. Papavasiliou), Athens, Greece.

Correspondence to: Sophie Mavrogeni, MD, 50 Esperou St, 175–61 P.Faliro, Athens, Greece; e-mail: soma{at}aias.gr

Objective: To examine the extent of cardiac muscle and sternocleidomastoid muscle (SCM) involvement detected by MRI measurement of T2 relaxation time in patients with Duchenne muscular dystrophy (DMD) and no cardiorespiratory symptoms.

Design: Prospective controlled study.

Setting: Teaching referral hospital and university hospital.

Subjects: Seventeen patients with DMD (age range, 7 to 25 years) and 17 age-matched control subjects. All patients were free of cardiac or respiratory complaints and had normal ECG, echocardiograph, and Holter monitor examination findings.

Methods: We assessed respiratory function by means of standard pulmonary function testing. MRI measurements included the T2 relaxation time of the myocardium and the SCM in patients and control subjects.

Results: The FVC and FEV1 values were lower in patients with DMD than in age-matched control subjects, whereas the FEV1/FVC ratio was normal in all subjects. Patients with DMD had lower T2 relaxation time of the heart (37.8 ± 6.1 ms vs 58.1 ± 7.1 ms, p < 0.001) and lower T2 relaxation time of the right SCM (24.5 ± 2.6 ms vs 42.2 ± 1.3 ms, p < 0.001) and left SCM (23.2 ± 3.2 ms vs 42.2 ± 1.6 ms, p < 0.001), compared to control subjects (± SD). In children (< 12 years of age), the T2 of the SCM was lower than that of the control subjects, but T2 of the heart did not differ between the two groups. In the patient group, T2 relaxation time of the heart decreased with age (r = – 0.80, p < 0.001). In patients with FVC < 80% of predicted, the T2 values of the heart were lower than the T2 values of patients with FVC ≥ 80% of predicted (35.6 ± 5.8 ms vs 41.8 ± 4.6 ms, p < 0.05).

Conclusions: MRI measurements of the T2 relaxation time in the myocardium and SCM of patients with DMD and no cardiorespiratory symptoms are abnormal, indicating altered tissue composition. These measurements may prove a clinically useful test for monitoring cardiac and respiratory muscle involvement in these patients.

Key Words: cardiac muscle • Duchenne muscular dystrophy • MRI • sternocleidomastoid muscle






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.